معرفی
Tove Grönroos is a Docent (Associate Professor) at the University of Turku's Department of Clinical Medicine and Senior Research Fellow leading the Preclinical PET Imaging Unit at the Turku PET Centre. Her dual roles focus on translational PET imaging to address critical gaps in cancer radiotherapy and neurological diagnostics.
Her research centers on developing PET tracers for tumor microenvironment analysis, specifically targeting radioresistance biomarkers like hypoxia, energy metabolism dysregulation, and inflammation in solid tumors. She also re-evaluates existing tracers for cancer imaging applications and whole-body metabolic changes affecting treatment outcomes.
Recent publications (2021-2024) reveal a strategic focus on oncology (head/neck cancer biomarkers), neurology (neonatal brain injury, neuropathic pain), and diabetes (islet graft imaging). Her work consistently bridges preclinical validation and clinical implementation, with tracers showing promise for treatment planning in radiotherapy.
As Head of the Preclinical PET Imaging Unit, she oversees a multidisciplinary team combining small animal PET technology with molecular biology techniques. The unit collaborates extensively with Turku University Hospital and Finnish research institutions to accelerate tracer adoption in clinical settings, particularly for personalized cancer therapy.
